1Thomson AK,Glasson EJ,Bittles AH. A long-term populationbased clinical and morbidity profile of Angelman syndrome in Western Australia:1953-2003[J].Disabil Rehabi1,2006,(5):299-305.
2Williams CA,Beaudet AL,Clayton-Smith J. Angelman syndrome 2005:updated consensus for diagnostic criteria[J].{H}American Journal of Medicdl Genetics,2006,(5):413-418.
3Minassian BA,DeLorey TM,Olsen RW. Angelman Syndrome:correlations between epilepsy phenotypes and genotypes[J].{H}Annals of Neurology,1998,(4):485-493.
4Varela MC,Kok F,Otto PA. Phenotypic variability in Angelman syndrome:Comparison among different deletion classes and between deletion and UPD subjects[J].{H}European Journal of Human Genetics,2004,(12):987-992.
5Elia M. Myoclonic status in nonprogressive envephalopathies:an Update[J].{H}EPILEPSIA,2009,(z5):41-44.
6Evangeliou A,Doulioglou V,Haidopoulou K. Ketogenic diet in a patient with Angelman syndrome[J].{H}Pediatrics International,2010,(5):831-834.
